Anti-TSG101 antibody (Ab30871)

Tumor susceptibility gene 101 protein, ESCRT-I complex subunit TSG101, TSG101

反应种属:Human, Mouse, Rat
抗原名称:Tumor susceptibility gene 101 protein
应用:WB, IHC, IF/ICC

详细信息

免疫原The exact immunogen used to generate this antibody is proprietary information.
宿主/亚型Rabbit / IgG
抗体类型Polyclonal
产品形式Liquid
纯化方式Affinity purification Immunogen
储存缓冲液pH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 1% BSA
储存条件运输条件: Blue Ice 推荐的短期储存时间: 1-2 weeks 推荐的短期储存条件: +4°C 推荐的长期储存条件: -20°C 储存信息: Avoid freeze / thaw cycle

背景信息

What is this antibody validated in? Anti-TSG101 antibody (ab30871) is a rabbit polyclonal antibody and is validated for use in Western Blot (WB), Immunohistochemistry (IHC-P), Immunocytochemistry/immunofluorescence (ICC/IF) in Human, Mouse, Rat samples. What is the molecular weight of TSG101? Anti-TSG101 (ab30871) specifically detects a band for TSG101 (UniProt: Q99816) at a molecular weight of 44kDa. Trusted by the scientific community Anti-TSG101 (ab30871) was first used in a scientific publication in 2006 and has been cited over 190 times in peer-reviewed journals.

文献引用 (264)

Tumour acidosis remodels the glycocalyx to control lipid scavenging and ferroptosis.

肿瘤酸中毒重塑糖萼,以控制脂质清除和铁死亡。

Bång-Rudenstam Anna, Cerezo-Magaña Myriam, Horvath Marton, Talbot Hugo, Gustafsson Emma, Jonathan Stevanus, Chakraborty Chaitali, Nissen Itzel, Gonçalves de Oliveira Kelin, Boukredine Axel, Beyer Sarah, Perez Julio Enriquez, Johansson Maria C, Kjellén Lena, Tykesson Emil, Malmström Anders, van Kuppevelt Toin H, Forsberg-Nilsson Karin, Esko Jeffrey D, Remeseiro Silvia, Bengzon Johan, Governa Valeria, Belting Mattias

Systemic Inflammation Modulates Clearance and Drives Extra-Hepatic Distribution of Extracellular Vesicles.

全身炎症调节细胞外囊泡的清除并驱动其向肝外分布。

Pavlova Svetlana, Mamand Doste R, Görgens André, Zickler Antje M, Zheng Wenyi, Liang Xiuming, Wiklander Oscar P B, Abedi-Valugerdi Manuchehr, Van Wonterghem Elien, Xie Junhua, Niu Zheyu, Roudi Samantha, Yan Dongnan, Makkar Ruhani, Zhou Guannan, Imami Koshi, Wood Matthew J A, Vandenbroucke Roosmarijn E, Gupta Dhanu, Andaloussi Samir El

Novel serum small extracellular vesicle miRNAs with multi-target RCA-CRISPR sensor for liver cancer detection.

利用多靶点 RCA-CRISPR 传感器检测新型血清小细胞外囊泡 miRNA 以进行肝癌检测。

Fan Tingting, Zhou Bo, Chen Hui, Liu Li-Ping, Ni Yong, Zhang Wei, Ye Lizhen, Chen Yifei, Zhang Dandan, Yang Shiqi, Bai Yu, Liu Funian, Zhi Cailian, Xu Guanghong, Zheng Bo, Lu Songlin, Qiu Cheng, Ding Zijian, Chen Yan, Jiang Yuyang

BMSC-derived exosomes facilitate osteogenesis and ameliorate ageing-related bone loss through restoring Th17/Treg homeostasis via the miR-21/Skp2/FoxO1 axis.

BMSC 衍生的外泌体通过 miR-21/Skp2/FoxO1 轴恢复 Th17/Treg 稳态,促进成骨作用并改善与衰老相关的骨质流失。

Wang Zeyu, Luo Jianhai, Yu Tong, Hu Pengcheng, Liu Jie

Adipocyte-Derived Extracellular Vesicles Endow Melanoma Cells with Stem-like Traits via PGC-1α-Mediated Mitochondrial Reprogramming.

脂肪细胞衍生的细胞外囊泡通过 PGC-1α 介导的线粒体重编程赋予黑色素瘤细胞干细胞样特征。

Giannitti Gaia, Marchesi Sara, Garavaglia Riccardo, Preosto Ivan, Carollo Emanuela, Sartori Patrizia, Fontana Fabrizio

Exosomal microRNAs of tuberculous pleural effusion orchestrating TGF-β signaling mediate pleural fibrosis.

结核性胸腔积液的外泌体微RNA通过调控TGF-β信号介导胸膜纤维化。

Co-localization of tau and TDP-43 after extracellular vesicle delivery to cells.

细胞外囊泡递送至细胞后,tau 和 TDP-43 发生共定位。

Aliakbari Farhang, Volkening Kathryn, Nayeri Zahra, Polat Aysegul Yucel, Donison Neil, Palik Jacqueline, Strong Michael J

Human amniotic mesenchymal stem cell-derived extracellular vesicles improve oocyte quality and embryonic development by increasing antioxidant capacity in aged mice.

人羊膜间充质干细胞衍生的细胞外囊泡通过提高老年小鼠的抗氧化能力来改善卵母细胞质量和胚胎发育。

La Boya, Jiang Chunyan, He Jia, Ni Man, Zhou Jing, Wu Huimin, Ning Song, Dai Wangjuan, Yan Zhengjie, Cui Yugui, Qin Lianju, Liu Jiayin

A modular strategy for extracellular vesicle-mediated CRISPR-Cas9 delivery through aptamer-based loading and UV-activated cargo release.

通过基于适配体的装载和紫外线激活的货物释放,实现细胞外囊泡介导的 CRISPR-Cas9 递送的模块化策略。

Elsharkasy Omnia M, Hegeman Charlotte V, Driedonks Tom A P, Liang Xiuming, Lansweers Ivana, Cotugno Olaf L, de Groot Ingmar Y, de Wit Zoë E M N J, Garcia-Guerra Antonio, Moorman Niels J A, Boonstra Sjoerd H, Bosman Esmeralda D C, Lefferts Juliet W, de Voogt Willemijn S, François Jerney J, van Wesel Annet C W, El Andaloussi Samir, Schiffelers Raymond M, Kooijmans Sander A A, Mastrobattista Enrico, Vader Pieter, de Jong Olivier G

TMTP1-Modified Small Extracellular Vesicles Target BRAF Mutation in Anaplastic Thyroid Cancer Reversing Vemurafenib Resistance With CRISPR/Cas9 Delivery

TMTP1修饰的小型细胞外囊泡靶向间变性甲状腺癌中的BRAF突变,并通过CRISPR/Cas9递送逆转维莫非尼耐药性

Shuo Zhang,Zhenrong Ji,Xiaoyu Cheng,Yue Ma,Mingliang Feng,Dasheng Cai,Tao Bai
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 27